情報源 > 更に詳しい情報[043]
参考文献

(1) Ayala A, Danese MD, Ladenson PW. When to treat mild hypothyroidism. Endocrinol Metab Clin North Am 2000; 29: 399-415.
(2) Tunbridge WMG, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 1977; 7: 481-493.
(3) Canaris GJ, Manowitz NR, Mayor GM, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000; 160: 526-534.
(4) Danese MD, Powe NR, Sawin CT, Ladenson PW. Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis. JAMA 1996; 276: 285-292.
(5) Ladenson PW, Singer PA, Ain KB, et al. American Thyroid Association guidelines for detection of thyroid dysfunction. Arch Intern Med 2000; 160: 1573-1575.
(6) Clinical practice guidelines for the evaluation and treatment of hyperthyroidism and hypothyroidism. Jacksonville, Fla.: American Association of Clinical Endocrinologists, 1996. (Accessed July 2, 2001, at http://www.aace.com/clinguideindex.htm)
(7) Glenn GC, Laboratory Testing Task Force of the College of American Pathologists. Practice parameter on laboratory panel testing for screening and case finding in asymptomatic adults. Arch Pathol Lab Med 1996; 120: 929-943.
(8) Periodic health examination: summary of AAFP policy recommendations and age charts, revision 4.0. Kansas City, Mo.: American Academy of Family Physicians, 2000.
(9) Precis: an update in obstetrics and gynecology: primary & preventive care. Washington, D.C.: American College of Obstetrics and Gynecology, 1998: 3-15.
(10) American College of Physicians. Screening for thyroid disease. Ann Intern Med 1998; 129: 141-143.
(11) Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore: Williams & Wilkins, 1996: 209-18.
(12) Vanderpump MP, Ahlquist JA, Franklyn JA, Clayton RN. Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism. BMJ 1996; 313: 539-544.
(13) Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999; 341: 549-555.
(14) Allan WC, Haddow JE, Palomaki GE, et al. Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen 2000; 7: 127-130.
(15) Leung AS, Miller LK, Koonings PP, Montoro M, Mestman JH. Perinatal outcome in hypothyroid pregnancies. Obstet Gynecol 1993; 81: 349-353.
(16) Lincoln SR, Ke RW, Kutteh WH. Screening for hypothyroidism in infertile women. J Reprod Med 1999; 44: 455-457.
(17) Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey. Clin Endocrinol (Oxf) 1995; 43: 55-68.
(18) Helfand M, Redfern CC. Screening for thyroid disease: an update. Ann Intern Med 1998; 129: 144-158. [Erratum, Ann Intern Med 1999; 130: 246.]
(19) Kumana CR, Cheung BMY, Lauder IJ. Gauging the impact of statins using number needed to treat. JAMA 1999; 282: 1899-1901.
(20) Elder J, McClelland A, O'Reilly DS, Packard CJ, Series JJ, Shepherd J. The relationship between serum cholesterol and serum thyrotropin, thyroxine and tri-iodothyronine concentrations in suspected hypothyroidism. Ann Clin Biochem 1990; 27: 110-113.
(21) Staub J-J, Althaus BU, Engler H, et al. Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. Am J Med 1992; 92: 631-642.
(22) Danese MD, Ladenson PW, Meinert CL, Powe NR. Effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J Clin Endocrinol Metab 2000; 85: 2993-3001.
(23) Diekman T, Lansberg PJ, Kastelein JJ, Wiersinga WM. Prevalence and correction of hypothyroidism in a large cohort of patients referred for dyslipidemia. Arch Intern Med 1995; 155: 1490-1495.
(24) Vanderpump MP, Tunbridge WMG, French JM, et al. The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community. Thyroid 1996; 6: 155-160.
(25) Hak AE, Pols HAP, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 2000; 132: 270-278.
(26) Zulewski H, Muller B, Exer P, Miserez AR, Staub JJ. Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. J Clin Endocrinol Metab 1997; 82: 771-776.
(27) Lindeman RD, Schade DS, LaRue A, et al. Subclinical hypothyroidism in a biethnic, urban community. J Am Geriatr Soc 1999; 47: 703-709.
(28) Cooper DS, Halpern R, Wood LC, Levin AA, Ridgway EC. L-thyroxine therapy in subclinical hypothyroidism: a double-blind, placebo-controlled trial. Ann Intern Med 1984; 101: 18-24.
(29) Nystrom E, Caidahl K, Fager G, Wikkelso C, Lundberg P-A, Lindstedt G. A double-blind cross-over 12-month study of L-thyroxine treatment of women with "subclinical" hypothyroidism. Clin Endocrinol (Oxf) 1988; 29: 63-75.
(30) Jaeschke R, Guyatt G, Gerstein H, et al. Does treatment with L-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism? J Gen Intern Med 1996; 11: 744-749.
(31) Kong WM, Sheikh M, Lumb P, et al. A randomized controlled trial of thyroxine treatment in mild subclinical hypothyroidism. In: Program & abstracts: the Endocrine Society's 82nd annual meeting, Toronto, June 21-24, 2000. Bethesda, Md.: Endocrine Society Press, 2000: 597. abstract.
(32) Meier C, Roth CB, Huber G, Guglielmetti M, Huber P, Staub JJ. Clinical and metabolic effects of thyroxine replacement in patients with mild thyroid failure: results from a double-blind placebo-controlled study. In: Program & abstracts: the Endocrine Society's 82nd annual meeting, Toronto, June 21-24, 2000. Bethesda, Md.: Endocrine Society Press, 2000: 573. abstract.
(33) Monzani F, Del Guerra P, Caraccio N, et al. Subclinical hypothyroidism: neurobehavioral features and beneficial effect of L-thyroxine treatment. Clin Investig 1993; 71: 367-371.
(34) Manciet G, Dartigues JF, Decamps A, et al. The PAQUID survey and correlates of subclinical hypothyroidism in elderly community residents in the southwest of France. Age Aging 1995; 24: 235-41.
(35) Baldini IM, Vita A, Mauri MC, et al. Psychopathological and cognitive features in subclinical hypothyroidism. Prog Neuropsychopharmacol Biol Psychiatry 1997; 21: 925-935.
(36) Centanni M, Cesareo R, Verallo O, et al. Reversible increase of intraocular pressure in subclinical hypothyroid patients. Eur J Endocrinol 1997; 136: 595-598.
(37) Biondi B, Fazio S, Palmieri EA, et al. Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. J Clin Endocrinol Metab 1999; 84: 2064-2067.
(38) Misiunas A, Niepomniszcze H, Ravera B, Faraj G, Faure E. Peripheral neuropathy in subclinical hypothyroidism. Thyroid 1995; 5: 283-286.
(39) Marqusee E, Haden ST, Utiger RD. Subclinical thyrotoxicosis. Endocrinol Metab Clin North Am 1998; 27: 37-49.
(40) Bona M, Santini F, Rivolta G, Grossi E, Grilli R. Cost-effectiveness of screening for subclinical hypothyroidism in the elderly: a decision-analytical model. Pharmacoeconomics 1998; 14: 209-216.
(41) Morreale de Escobar G, Obregon MJ, Escobar del Rey F. Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia? J Clin Endocrinol Metab 2000; 85: 3975-3987.
(42) Singer PA, Cooper DS, Levy EG, et al. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. JAMA 1995; 273: 808-812.
(43) Parle JV, Franklyn JA, Cross KW, Jones SC, Sheppard MC. Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol (Oxf) 1991; 34: 77-83.
(44) Weetman AP. Hypothyroidism: screening and subclinical disease. BMJ 1997; 314: 1175-1178.

もどる